Volume 10, Issue 4 (July & August 2019)                   BCN 2019, 10(4): 323-332 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Torkaman-Boutorabi A, Seifi F, Akbarabadi A, Toolee H, Sadat-Shirazi M, Vousooghi N et al . Morphine Exposure and Enhanced Depression-like Behaviour Confronting Chronic Stress in Adult Male Offspring Rat. BCN 2019; 10 (4) :323-332
URL: http://bcn.iums.ac.ir/article-1-1021-en.html
1- Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Research Center for Cognitive and Behavioral Sciences, Tehran University of Medical Sciences, Tehran, Iran.
2- Department of Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.
3- Faculty of Veterinary Medicine, Garmsar Branch, Islamic Azad University, Garmsar, Iran.; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
4- Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
5- Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. ; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
6- Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Full-Text [PDF 1815 kb]       |   Abstract (HTML) 
1. Introduction
Addiction is a multifactorial disorder with genetic, neurobiological, and psychosocial correlates (Goodman, 2008; Hurd, 2006). Drug addiction is a severe, chronically relapsing neuro-psychiatric disorder. According to Koob and LeMoal definition, addiction is characterized by the compulsion to seek and take drugs, the loss of control over limiting the intake, and the occurrence of a negative emotional state reflecting a withdrawal syndrome when there is no access to the drug (Koob & Le Moal, 1997).
Depression is comorbid with addiction and using illegal drugs as self-medication for depression, but prolonged drug use can exacerbate the severity of depression and increase drug intake (Bruijnzeel, Repetto, & Gold, 2004; Crist et al., 2013). Stress is a major environmental factor which is usually seen in the etiology of mood disorders (Charney & Manji, 2004; Paykel, 2003). Stress strongly implicated in both precipitation of depressive episodes (Kendler, Thornton, & Gardner, 2000; Willner, Scheel-Kruger, & Belzung, 2013) and relapse in drug abuse (Shaham, Shalev, Lu, De Wit, & Stewart, 2003).
There is considerable overlap in the neurobiological substrates of depression and addiction (Bruijnzeel et al., 2004; Markou, Kosten, & Koob, 1998). Epigenetic changes are described as an alteration in gene expression without altering in DNA sequences, which include changes in DNA methylation, histone modifications, and micro-RNA. Factors such as stress and abusing drugs could induce epigenetic changes and affect neuropsychiatric behaviors (Bagot, Labonte, Pena, & Nestler, 2014; Nestler, 2014; Robison & Nestler, 2011).
Based on some evidence, 50% of hospitalized children for the psychiatric disorder had addicted parents. Alcohol-abusing parents increase the risk of mental health problems such as depression, suicidal attempts, antisocial behavior, and drug abuse in children (Balsa, Homer, & French, 2009; Christoffersen & Soothill, 2003). 
Cortisol level increases during stress and in a depressed patient (Dinan, 1994; Gold, Goodwin, & Chrousos, 1988; Reus & Miner, 1985; Sachar et al., 1973). Johnson and colleague used repeated corticosterone injection as a chronic stressor for creating a rat model of depression following stressful events (Johnson, Fournier, & Kalynchuk, 2006). Previous investigations revealed that chronic stress would lead to anhedonia-like symptoms like reduced preference in sucrose (Wallace et al., 2009; Wook Koo et al., 2016). Our previous research established that parental morphine exposure before mating could affect anxiety-like behavior in the first generation but not in the second generation (submitted data).  
In this study, we investigated the effect of parental (maternal and or paternal) morphine exposure- 10 days before gestation- on the depression state of the offspring. Also, we evaluated chronic mild stress-induced depression in offspring by using chronic corticosterone injection as a model of mild chronic stress. 
2. Methods
2.1. Study animals

Adult male and female Wistar rats (7 weeks old) were purchased from Pasteur Institute and kept in cages (four rats in each cage). All animals were maintained at controlled light-dark cycle (12:12 h, lights on at 7.00 AM). The temperature was kept at 23±1°C, and the humidity was constant. They had free access to food and water except during the behavioral test. After two weeks of familiarization, the animals were randomized into four groups. All experiments were approved by Tehran University of Medical Sciences Ethics Committee, matching the national guidelines for animal care. 

2.2. Experimental procedure
2.2.1. Morphine-exposure protocol

Twenty-four male and twenty-four female Wistar rats were exposed to oral morphine sulfate (Temad, Iran) administration. Oral morphine administration protocol performed as described before (Zanjani & Sabetkasaei, 2010). Morphine sulfate was given in increasing concentrations, as mentioned in Table 1. Sucrose (2%) was added to morphine to diminish the bitter taste of morphine. The control group comprising eight male and eight female rats only received sucrose (2%). Morphine administration and mating protocol are shown in Figure 1. 

2.2.2. Mating protocol
As shown in Figure 1A, ten days after the last morphine intake, the animals were prepared for mating as described below: 1. Healthy male and healthy female; 2. Healthy female and morphine-abstinent male; 3. Healthy male and morphine-abstinent female; and 4. Morphine-abstinent male and female.
In each group, one male and one female rat were put in one cage. After parturition, the numbers of live and dead births were recorded. During lactation, maternal care and weight of the infant was monitored. Male offspring grouped into four: 1. Animals with both healthy parents (control); 2. Paternal Morphine-Exposed offspring (PME); 3. Maternal Morphine-Exposed offspring (MME); and 4. Offspring with both morphine-exposed parents (PME+MME). 
2.3. Behavioral tests
2.3.1. Sucrose Preference Test

In laboratory rodents, the two-bottle choice paradigm is usually used for sucrose preference as an index of anhedonia, particularly in stress-based models of depression (Overstreet, 2012). Preference is calculated as the sucrose intake (volume of liquid consumption) divided by the total fluid intake.
All animals should be deprived of water and food 20 hours before the behavioral test. In this time, each rat is placed in the cage individually. Animals were transferred to testing room 30 minutes before starting the test. In the test day, each rat can choose between two bottles: sucrose dissolved in water (1%) and tap water. The bottles were put across left and right sides of the cages. At the end of one hour, the volume of sucrose and water consumption was measured for each rat, and sucrose preference was calculated as follows: the sucrose preference (%)=[sucrose consumption/ (sucrose consumption+water consumption)] *100.
2.3.2. Forced Swimming Test
Forced Swimming Test (FST) is a behavioral test to assess depression-like behavior in rodents (Porsolt, Le Pichon, & Jalfre, 1977). Briefly, a rat is placed in a Plexiglas cylinder (60 cm height, 30 cm diameter) filled with water with a height of 30 cm. Water temperature is adjusted to 25° C. Each rat is allowed to swim for 5 minutes, and a video camera took the recording from above the cylinder. The latency time to immobility and total time of immobility (lack of motion of the whole body) are used as an index of depression-like behavior. 
2.3.3. Inducing mild chronic stress
We used repetitive corticosterone injection as a chronic stressor. All animals were handled once a day for seven days before corticosterone injection. As shown in Figure 1B and 1C, the rats were treated with corticosterone daily for 21 days. All behavioral tests were performed 24 h after the last injection.
Corticosterone (Sigma-Aldrich, UK) was dissolved in 0.9% saline with 2% (x)-Sorbian mono-9-octadecenoate poly(Oxy-1, 2-ethanediol) (Tween-80; Sigma-Aldrich) and injected subcutaneously once per day between 9:00 AM and 11:00 AM. All animals were weighed every day. Corticosterone was injected in 5, 10, and 20 mg/kg dose to drug-naive rats (Figure 1B) and the non-effective dose was chosen for offspring with morphine-exposed parent(s) (Figure 1C). 


2.4. Statistical analysis
We used SPSS version 21 for data analyses. The collected data were analyzed with 1-way ANOVA. Tukey’s multiple comparison test was used for finding differences between groups. The obtained data were expressed as Mean±SD of eight animals. 
3. Results
The mortality rate increase in the offspring of the morphine-abstinent parent(s): As shown in Table 2, mortality rate increased among the offspring of morphine-exposed parent(s) (χ2=31.889, P <0.001). There were no differences in weight or number of infants per parturition among groups. Depression-like behavior increase in offspring of morphine-abstinent rats:

Figure 2 shows depression-like behavior in the offspring of paternal and or maternal morphine-exposed parent(s) compared with the offspring of drug-naive parents. As shown in Figure 2A, the offspring of morphine-abstinent parents have low sucrose preference compared to the offspring of the drug-naive parent(s) (F 3,28=3.766, P=0.02). In FST, both latency to immobility and the total time of immobility changed in the offspring of one and or two morphine-abstinent parent(s) (panel C and D). Latency time decreased in offspring of one and or two morphine-abstinent parent(s) in comparison to the offspring of drug-naive animals (F3,28=42.833, P<0.001).
Animals with both morphine-abstinent parents showed a significant reduction in latency time compared with maternal morphine-exposed animals (P<0.01). Total time of immobility increased among the offspring of morphine-exposed parent(s) (F3,28=19.686, P<0.001). The total time of immobility increased in morphine-exposed parents in comparison with one morphine-exposed parent (P<0.01). Chronic corticosterone administration increased depression-like behavior dose-dependently.
Figure 3 demonstrated the chronic corticosterone administration increased depression-like behavior in drug-naive animals dose-dependently. Figure 3A revealed that sucrose preference decreased in corticosterone-received rats compared with the saline-treated rats (F3,28=6.025, P=0.003]. The latency to immobility and total time of immobility respectively decrease and increase in chronic corticosterone administration dose-dependently in FST (F3,28=5.260, P=0.005; F 3,28=5.386, P<0.005) (Figure 3B and 3C). The weight of each rat recorded daily; there were no changes in weight loss between groups (data not shown).

Chronic mild stressor increased depression-like behavior in the offspring of morphine-exposed rats: 
Figure 4 shows that non-effective dose (5 mg/kg) of corticosterone increases depression-like behavior in the offspring of paternal and or maternal morphine-exposed animals. Figure 4A revealed that sucrose preference (in confronting with mild chronic stressor) only changed in the offspring of both morphine-abstinent parents compared with offspring of drug-naive rats (F3, 28=4.312, P =0.013). FST established that offspring of the morphine-exposed parent(s) are more susceptible to depression in opposing mild chronic stress compared to the control group (latency to immobility: F3,28=12.499, P<0.001; the total time of immobility: F3,28=20.848, P<0.001). There was no statistical difference between weight loss among groups (data not shown).

4. Discussion
Previous studies indicate that parental morphine exposure can disrupt neurochemical and neurophysiological features in the offspring (Cicero et al., 1991; Sarkaki, Assaei, Motamedi, Badavi, & Pajouhi, 2008). Also, our previous work reveals that parental morphine exposure before gestation leads to memory deficit, changing in pain perception, and increasing tolerance to morphine in male offspring (data not published yet). In this study, we found that parental morphine exposure could impress depression in offspring. The accumulating data indicate that µ-opioid receptor and β-endorphin are expressed in the male reproductive organ (Albrizio, Guaricci, Calamita, Zarrilli, & Minoia, 2006). Furthermore, µ-, κ- and δ-opioid receptors are expressed in the oocyte (Agirregoitia et al., 2012), so morphine can induce the trans-generational effect. 
As mentioned previously, a variety of psychopathologies like depression, substance abuse, and suicidal attacks are common among children with addicted parents (Balsa et al., 2009; Christoffersen & Soothill, 2003). According to Fuller-Thomson study, children with alcoholic or addicted parents, experience depression 69% more than other children (Fuller-Thomson, Katz, Phan, Liddycoat, & Brennenstuhl, 2013) these studies have not examined if gender differences exist nor have they controlled for a range of potential explanatory factors. Using a regionally representative sample of 6268 adults from the 2005 Canadian Community Health Survey (response rate=83%. Additional investigation on laboratory animals has verified that morphine exposure before gestation alters the endogenous opioid system in the offspring (Cicero et al., 1991).
Paternal morphine exposure leads to increasing β-endorphin in hypothalamus and corticosterone level in serum in the female offspring (Cicero et al., 1991). Moreover, maternal morphine exposure can attenuate quinpirole-induced corticosterone in both the first and second generation male offspring (Byrnes, Johnson, Carini, & Byrnes, 2013). As approved in human studies (Fuller-Thomson et al., 2013), we confirmed that the depression rate was higher among offspring with morphine-exposed parent(s) in comparison to offspring of the control parents. Additionally, low sucrose preference in the offspring of both morphine-exposed parents, decrease in latency to immobility and an increase in the total time of immobility in FST prove our hypothesis. 
Johnson et al. reported that repeated corticosterone injections increased depression-like behavior dose-dependently, and they suggested that repeated corticosterone injections dysregulated Hypothalamic-Pituitary-Adrenal (HPA) axis and consequently produced depressive disorder (Johnson, Carini, Schenk, Stewart, & Byrnes, 2006). We also found that the offspring of morphine-exposed rats were more vulnerable to depression in response to mild chronic stressor like low doses of corticosterone. The obtained data indicate that administration of corticosterone with low dose (5 mg/kg) does not induce depression-like behavior in the offspring of the healthy rats but can cause depression-like behavior in the offspring of the morphine-exposed rats.
This effect may have occurred following the HPA axis dysregulation (Cicero et al., 1991). Mild stressor might increase corticosterone level in the offspring of morphine-exposed rats more than offspring of the healthy rats, and probably such effect is mediated via the enhanced level of corticosterone in plasma. A study by Houshyar and colleagues reveals that chronic morphine administration results in the persistent elevation of basal plasma corticosterone level approximately ten times more than the control group (Houshyar, Galigniana, Pratt, & Woods, 2001).  
Hippocampus is an important area involved in depression (Sheline, Mittler, & Mintun, 2002). Sarkaki et al. reported that paternal morphine exposure disrupted hippocampal synaptic plasticity in male offspring (Sarkaki et al., 2008). The Paraventricular Nucleus (PVN) of the hypothalamus contains neurons with corticotropin-releasing factor, and these neurons integrate information pertinent to stress. In PVN, excitatory afferent from the amygdala and inhibitory afferent from hippocampus are prominent. Moreover, ascending monoamine inputs, inputs from the periphery, and inhibitory inputs from circulating glucocorticoids are convergent in PVN. Chronic stress and continuous rise of glucocorticoids decrease expression of Brain-Derived Neurotrophic Factor (BDNF) in the hippocampus. 
BDNF has a significant role in neurons survival, and its decreasing may contribute to CA3 atrophy. Losing CA3 neurons increased susceptibility to psychiatric diseases such as depression and anxiety (Nestler, Hyman, & Malenka, 2015). Likewise, prenatal morphine exposure decreases Long-Term Depression (LTD) in CA1 pyramidal neurons (Yang et al., 2003). These changes in neuronal plasticity in the hippocampus may affect depression-like behavior in the offspring of the morphine-exposed parent(s). Evidence proved that morphine exposure before parturition or during mothering change maternal care (Bridges & Grimm, 1982; Miranda-Paiva, Nasello, Yin, & Felicio, 2001; Slamberova, Szilagyi, & Vathy, 2001). Other investigations revealed that morphine administration in adolescence could alter maternal-care-like nursing and contact time during lactation (Johnson, Carini, Schenk, Stewart, & Byrnes, 2011).
Finally, in addition to the role of HPA axis, psychological changes in the offspring of addict rats, another possible reason for such depressive disorder is an epigenetic transmission. Morphine can directly affect epigenetic germ cells. These changes impress developmental processes in the embryo. The mechanisms which cause such trans-generational effect are unknown, and other investigation should be conducted to find exact mechanisms of such effects.

Ethical Considerations
Compliance with ethical guidelines

all experiments were approved by Tehran University of Medical Sciences ethic committee.
The authors acknowledge the grant support from the Tehran University of Medical Sciences (No.
Authors' contributions
Conceptualization: Mohammad-Reza Zarrindast; Methodology: Fereshteh Seifi, Ardeshir Akbarabadi, HeidarToollee; Investigation: Fereshteh Seifi, Ardeshir Akbarabadi, HeidarToollee; Writing-original draft: Mitra-Sadat Sadat-Shirazi; Writing-review & editing: Anahita Torkaman-Boutorabi; Funding acquisition: Anahita Torkaman-Boutorabi; Resources, Mohammad-Reza Zarrindast; Supervision: Mohammad-Reza Zarrindast, Anahita Torkaman-Boutorabi, Mitra-Sadat Sadat-Shirazi, Nasim Vousooghi.
Conflict of interest
There is no conflict of interests. 

  1. Agirregoitia, E., Peralta, L., Mendoza, R., Exposito, A., Ereno, E. D., Matorras, R., et al. (2012). Expression and localization of opioid receptors during the maturation of human oocytes. Reproductive BioMedicine Online, 24(5), 550-7. [DOI:10.1016/j.rbmo.2012.02.007] [PMID]
  2. Albrizio, M., Guaricci, A. C., Calamita, G., Zarrilli, A., & Minoia, P. (2006). Expression and immunolocalization of the mu-opioid receptor in human sperm cells. Fertility and Sterility, 86(6), 1776-9. [DOI:10.1016/j.fertnstert.2006.04.037] [PMID]
  3. Bagot, R. C., Labonté, B., Peña, C. J., & Nestler, E. J. (2014). Epigenetic signaling in psychiatric disorders: stress and depression. Dialogues in Clinical Neuroscience, 16(3), 281-95. [PMID] [PMCID]
  4. Balsa, A. I., Homer, J. F., & French, M. T. (2009). The health effects of parental problem drinking on adult children. Journal of Mental Health Policy and Economics, 12(2), 55-66. [PMID]
  5. Bridges, R. S., & Grimm, C. T. (1982). Reversal of morphine disruption of maternal behavior by concurrent treatment with the opiate antagonist naloxone. Science, 218(4568), 166-8. [DOI:10.1126/science.7123227] [PMID]
  6. Bruijnzeel, A. W., Repetto, M., & Gold, M. S. (2004). Neurobiological mechanisms in addictive and psychiatric disorders. Psychiatric Clinics of North America, 27(4), 661-74. [DOI:10.1016/j.psc.2004.06.005] [PMID]
  7. Byrnes, J. J., Johnson, N. L., Carini, L. M., & Byrnes, E. M. (2013). Multigenerational effects of adolescent morphine exposure on dopamine D2 receptor function. Psychopharmacology (Berl), 227(2), 263-72. [DOI:10.1007/s00213-012-2960-1] [PMID] [PMCID]
  8. Charney, D. S., & Manji, H. K. (2004). Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Science Signaling, 2004(225), re5. [DOI:10.1126/stke.2252004re5] [PMID]
  9. Christoffersen, M. N., & Soothill, K. (2003). The long-term consequences of parental alcohol abuse: a cohort study of children in Denmark. Journal of Substance Abuse Treatment, 25(2), 107-16. [DOI:10.1016/S0740-5472(03)00116-8]
  10. Cicero, T. J., Adams, M. L., Giordano, A., Miller, B. T., O’Connor, L., & Nock, B. (1991). Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring. Journal of Pharmacology and Experimental Therapeutics, 256(3), 1086-93.
  11. Crist, R. C., Ambrose-Lanci, L. M., Vaswani, M., Clarke, T. K., Zeng, A., Yuan, C., et al. (2013). Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug and Alcohol Dependence, 127(1-3), 122-8. [DOI:10.1016/j.drugalcdep.2012.06.023] [PMID] [PMCID]
  12. Dinan, T. G. (1994). Glucocorticoids and the genesis of depressive illness a psychobiological model. The British Journal of Psychiatry, 164(3), 365-71. [DOI:10.1192/bjp.164.3.365] [PMID]
  13. Fuller-Thomson, E., Katz, R. B., Phan, V. T., Liddycoat, J. P., & Brennenstuhl, S. (2013). The long arm of parental addictions: the association with adult children’s depression in a population-based study. Psychiatry Research, 210(1), 95-101. [DOI:10.1016/j.psychres.2013.02.024] [PMID]
  14. Gold, P. W., Goodwin, F. K., & Chrousos, G. P. (1988). Clinical and biochemical manifestations of depression. New England Journal of Medicine, 319(6), 348-53. [DOI:10.1056/NEJM198808113190606] [PMID]
  15. Goodman, A. (2008). Neurobiology of addiction: An integrative review. Biochemical Pharmacology, 75(1), 266-322. [DOI:10.1016/j.bcp.2007.07.030] [PMID]
  16. Houshyar, H., Galigniana, M. D., Pratt, W. B., & Woods, J. H. (2001). Differential responsivity of the hypothalamic‐pituitary‐adrenal axis to glucocorticoid negative‐feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. Journal of Neuroendocrinology, 13(10), 875-86. [DOI:10.1046/j.1365-2826.2001.00714.x] [PMID]
  17. Hurd, Y. L. (2006). Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors. CNS Spectrums, 11(11), 855-62. [DOI:10.1017/S1092852900015005] [PMID]
  18. Johnson, N. L., Carini, L., Schenk, M. E., Stewart, M., & Byrnes, E. M. (2011). Adolescent opiate exposure in the female rat induces subtle alterations in maternal care and transgenerational effects on play behavior. Frontiers in Psychiatry, 2, 29. [DOI:10.3389/fpsyt.2011.00029]
  19. Johnson, S. A., Fournier, N. M., & Kalynchuk, L. E. (2006). Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behavioural Brain Research, 168(2), 280-8. 019 [DOI:10.1016/j.bbr.2005.11.019] [PMID]
  20. Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2000). Stressful life events and previous episodes in the etiology of major depression in women: An evaluation of the “kindling” hypothesis. The American Journal of Psychiatry, 157(8), 1243-51. [DOI:10.1176/appi.ajp.157.8.1243] [PMID]
  21. Koob, G. F., & Le Moal, M. (1997). Drug abuse: Hedonic homeostatic dysregulation. Science, 278(5335), 52-8. [DOI:10.1126/science.278.5335.52] [PMID]
  22. Markou, A., Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology, 18(3), 135-74. [DOI:10.1016/S0893-133X(97)00113-9]
  23. Miranda-Paiva, C. M., Nasello, A. G., Yin, A. J., & Felicio, L. F. (2001). Morphine pretreatment increases opioid inhibitory effects on maternal behavior. Brain Research Bulletin, 55(4), 501-5. [DOI:10.1016/S0361-9230(01)00549-4]
  24. Nestler, E. J. (2014). Epigenetic mechanisms of drug addiction. Neuropharmacology, 76(part B), 259-68. [DOI:10.1016/j.neuropharm.2013.04.004] [PMID] [PMCID]
  25. Nestler, E., Hyman, S., & Malenka, R. (2015). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. New York: McGraw-Hill Education.
  26. Overstreet, D. H. (2012). Modeling depression in animal models. In: F. H. Kobeissy (eds.), Psychiatric Disorders (pp. 125-44). Berlin: Springer. [DOI:10.1007/978-1-61779-458-2_7] [PMID]
  27. Paykel, E. S. (2003). Life events and affective disorders. Acta Psychiatrica Scandinavica, 108(s418), 61-6. [DOI:10.1034/j.1600-0447.108.s418.13.x]
  28. Porsolt, R. D., Le Pichon, M., & Jalfre, M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature, 266(5604), 730-2. [DOI:10.1038/266730a0] [PMID]
  29. Reus, V. I., & Miner, C. (1985). Evidence for physiological effects of hypercortisolemia in psychiatric patients. Psychiatry Research, 14(1), 47-56. [DOI:10.1016/0165-1781(85)90088-5]
  30. Robison, A. J., & Nestler, E. J. (2011). Transcriptional and epigenetic mechanisms of addiction. Nature Reviews Neuroscience, 12(11), 623-37. [DOI:10.1038/nrn3111] [PMID] [PMCID]
  31. Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., & Gallagher, T. (1973). Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Archives of General Psychiatry, 28(1), 19-24. [DOI:10.1001/archpsyc.1973.01750310011002] [PMID]
  32. Sarkaki, A., Assaei, R., Motamedi, F., Badavi, M., & Pajouhi, N. (2008). Effect of parental morphine addiction on hippocampal long-term potentiation in rats offspring. Behavioural Brain Research, 186(1), 72-7. [DOI:10.1016/j.bbr.2007.07.041] [PMID]
  33. Shaham, Y., Shalev, U., Lu, L., De Wit, H., & Stewart, J. (2003). The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology, 168(1-2), 3-20. [DOI:10.1007/s00213-002-1224-x] [PMID]
  34. Sheline, Y. I., Mittler, B. L., & Mintun, M. A. (2002). The hippocampus and depression. European Psychiatry, 17 (Suppl. 3), 300-5. [DOI:10.1016/S0924-9338(02)00655-7]
  35. Slamberova, R., Szilagyi, B., & Vathy, I. (2001). Repeated morphine administration during pregnancy attenuates maternal behavior. Psychoneuroendocrinology, 26(6), 565-76. [DOI:10.1016/S0306-4530(01)00012-9]
  36. Wallace, D. L., Han, M. H., Graham, D. L., Green, T. A., Vialou, V., Iniguez, S. D., et al. (2009). CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nature Neuroscience, 12(2), 200-9. [DOI:10.1038/nn.2257] [PMID] [PMCID]
  37. Willner, P., Scheel-Kruger, J., & Belzung, C. (2013). The neurobiology of depression and antidepressant action. Neuroscience & Biobehavioral Reviews, 37(10 Pt 1), 2331-71. [DOI:10.1016/j.neubiorev.2012.12.007] [PMID]
  38. Wook Koo, J., Labonte, B., Engmann, O., Calipari, E. S., Juarez, B., Lorsch, Z., et al. (2016). Essential role of mesolimbic brain-derived neurotrophic factor in chronic social stress-induced depressive behaviors. Biological Psychiatry, 80(6), 469-78. [DOI:10.1016/j.biopsych.2015.12.009] [PMID] [PMCID]
  39. Yang, S. N., Huang, L. T., Wang, C. L., Chen, W. F., Yang, C. H., Lin, S. Z., et al. (2003). Prenatal administration of morphine decreases CREBSerine‐133 phosphorylation and synaptic plasticity range mediated by glutamatergic transmission in the hippocampal CA1 area of cognitive‐deficient rat offspring. Hippocampus, 13(8), 915-21. [DOI:10.1002/hipo.10137] [PMID]
  40. Zanjani, T. M., & Sabetkasaei, M. (2010). Study of the intraplantar injection of lidocaine and morphine on pain perception and the influence of morphine dependence and withdrawal on lidocaine-induced analgesia in rats. Iranian Biomedical Journal, 14(4), 164-70. [PMID] [PMCID]
Type of Study: Original | Subject: Behavioral Neuroscience
Received: 2017/09/8 | Accepted: 2018/03/3 | Published: 2019/07/1

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb